Encouraging Trends in Modern Phase 1 Oncology Trials

To the Editor: Critics have raised a fundamental ethical challenge about phase 1 cancer research. They point to an expected paucity of benefits, since approximately 5% of patients in phase 1 trials are reported to have tumor shrinkage. We conducted a search of the literature using PubMed to…

https://ift.tt/2tajPsT